IRIS
FERRARI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.250
NA - Nord America 8.031
EU - Europa 4.545
SA - Sud America 1.192
AF - Africa 466
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.518
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.841
SG - Singapore 3.055
CN - Cina 2.213
VN - Vietnam 1.248
IE - Irlanda 935
BR - Brasile 922
IT - Italia 713
SE - Svezia 707
HK - Hong Kong 642
DE - Germania 492
FI - Finlandia 399
FR - Francia 394
TR - Turchia 385
ZA - Sudafrica 328
NL - Olanda 277
IN - India 135
GB - Regno Unito 125
CA - Canada 112
UA - Ucraina 106
RU - Federazione Russa 97
AR - Argentina 96
JP - Giappone 73
BD - Bangladesh 70
IQ - Iraq 64
KR - Corea 55
MX - Messico 50
CI - Costa d'Avorio 43
EC - Ecuador 41
PK - Pakistan 40
PL - Polonia 40
AT - Austria 38
BE - Belgio 37
VE - Venezuela 37
ID - Indonesia 36
CO - Colombia 34
PH - Filippine 34
ES - Italia 33
TH - Thailandia 31
DK - Danimarca 29
UZ - Uzbekistan 27
MA - Marocco 23
AU - Australia 22
LT - Lituania 22
KE - Kenya 21
RO - Romania 20
TW - Taiwan 20
PY - Paraguay 17
CZ - Repubblica Ceca 15
EG - Egitto 14
SA - Arabia Saudita 14
UY - Uruguay 13
CL - Cile 11
OM - Oman 11
BO - Bolivia 10
JO - Giordania 10
AZ - Azerbaigian 9
IL - Israele 9
MY - Malesia 9
PE - Perù 9
BG - Bulgaria 8
KZ - Kazakistan 8
TN - Tunisia 8
CH - Svizzera 7
GR - Grecia 7
IR - Iran 7
LV - Lettonia 7
PA - Panama 7
AE - Emirati Arabi Uniti 6
PT - Portogallo 6
AL - Albania 5
BY - Bielorussia 5
EU - Europa 5
NP - Nepal 5
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LB - Libano 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
SY - Repubblica araba siriana 4
BB - Barbados 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
LU - Lussemburgo 3
NG - Nigeria 3
NI - Nicaragua 3
SN - Senegal 3
TG - Togo 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
CR - Costa Rica 2
GA - Gabon 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
Totale 22.485
Salva come PNG Salva come JPEG
Città #
Singapore 1.450
Ashburn 1.003
Dublin 934
San Jose 897
Chandler 729
Santa Clara 620
Hong Kong 615
Dallas 503
Beijing 449
Dearborn 409
Ho Chi Minh City 376
Johannesburg 307
Izmir 300
Hanoi 294
Boardman 280
Nanjing 250
Princeton 200
Parma 198
Munich 196
Lauterbourg 195
Shanghai 158
Ann Arbor 155
Wilmington 151
Los Angeles 150
New York 136
Helsinki 134
Jacksonville 108
Columbus 106
São Paulo 94
Shenyang 77
Hebei 74
Hefei 65
Nanchang 64
Moscow 62
Milan 61
Tianjin 59
Da Nang 57
Tokyo 56
Haiphong 55
Chicago 54
Kunming 54
Seattle 53
Jinan 51
The Dalles 48
Council Bluffs 47
Guangzhou 47
Buffalo 44
Düsseldorf 44
Abidjan 43
Toronto 43
Grafing 42
Jiaxing 42
Rio de Janeiro 42
Changsha 41
Bremen 39
Frankfurt am Main 39
Kocaeli 39
San Mateo 36
London 35
Stockholm 35
Houston 34
Norwalk 34
Montreal 33
Rome 33
Brussels 32
Des Moines 32
Nuremberg 31
Zhengzhou 30
Warsaw 29
Turku 28
Hải Dương 27
Bologna 26
Seoul 26
Vienna 26
Marseille 25
Tashkent 25
Baghdad 24
Brooklyn 23
Taastrup 23
Belo Horizonte 22
Phoenix 22
Curitiba 21
Hangzhou 21
Mestre 21
Atlanta 19
Denver 19
Jakarta 19
Brasília 18
Orem 18
Pune 18
Bengaluru 17
Boston 17
Can Tho 16
Mexico City 16
Washington 16
Chennai 15
Nairobi 15
Ningbo 15
Reggio Emilia 15
Rockville 15
Totale 13.861
Salva come PNG Salva come JPEG
Nome #
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 303
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 286
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 282
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 252
A simplified sars-cov-2 pseudovirus neutralization assay 208
The anti-COVID-19 vaccine unveils latent systemic sclerosis 191
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study 181
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 175
Therapeutic potential of co-signaling receptor modulation in hepatitis B 174
Metabolic regulation of the HBV-specific T cell function 173
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 171
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 168
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 167
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients 167
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 163
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 157
Alterazioni della funzionalità tiroidea in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone e ribavirina e correlazione con la risposta alla terapia antivirale. 157
ALTERAZIONI DELLA FUNZIONALITA’ TIROIDEA IN PAZIENTI AFFETTI DA EPATITE CRONICA ATTIVA DA VIRUS C IN TERAPIA CON INTERFERONE E RIBAVIRINA E CORRELAZIONE CON LA RISPOSTA ALLA TERAPIA ANTIVIRALE 157
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 157
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 156
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 154
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 154
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 151
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 149
Adaptive immunity in HBV infection 148
HBV immune-therapy: From molecular mechanisms to clinical applications 148
Le linee di ricerca strategiche di un'azienda ospedaliero-universitaria: proposta di un metodo qualiquantitativo 147
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 145
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 145
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 144
[An outbreak type A hepatitis in a family group living in a village near Parma. Epidemiologic evaluation and prophylaxis (author's transl)] 143
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV. J. Hepatol. 142
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 141
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 141
T cell regulation in HBV-related chronic liver disease 141
STUDIO E COMPARAZIONE DELLE ALTERAZIONI DI FUNZIONALITA’ TIROIDEA INDOTTE DA INTERFERONE NEI SOGGETTI CON EPATITE CRONICA ATTIVA DA VIRUS C RISPETTO A SOGGETTI DI CONTROLLO 140
Tiroiditi distruttive in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone: nostra esperienza 140
Course of Graves' disease in interferon-treated patients with chronic hepatitis C virus infection and in uninfected patients 137
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 137
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV 136
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 131
COMPOSTO FARMACEUTICO PER L’USO IN UN TRATTAMENTO TERAPEUTICO DELL’INFEZIONE CRONICA DA HBV E METODO PER L’IDENTIFICAZIONE DI LINFOCITI ESAURITI 130
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 127
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 127
[Infectious agents in the G.I. tract diseases (author's transl)] 124
[The cell-mediated antiviral immune response. The possible therapeutic implications for chronic hepatitis B viral infection] 124
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 122
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 122
What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group 121
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 121
RNA Interference Therapy with ARC-520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection 120
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 120
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 119
Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: Results of an Italian multicenter study 119
Practice of proctology among general surgery residents and young specialists in Italy: a snapshot survey 118
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 118
Clinical spectrum of cryoglobulinaemic neuropathy 117
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection 117
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 116
[Non-A, non-B hepatitis. Seroimmunological, epidemiological and clinical findings] 116
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B 115
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 114
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection 114
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probably related to integrase inhibitor use 114
Clinical features of hepatitis delta virus infection in a northern Italian area 113
Fine specificity of the human T cell response to hepatitis B virus core antigen 112
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 111
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 111
A global scientific strategy to cure hepatitis B 110
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines 110
[The immunopathogenesis of hepatitis B] 109
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 107
Comparative pathogenesis of HBV and HCV 107
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 107
Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C? 106
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 106
Immune pathogenesis of hepatitis B 106
[Hepatitis B virus infection in a hospital population in Parma: implementation of a vaccination program] 106
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection 106
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 105
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 105
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 105
Assessment of neutrophil gelatinase-associated lipocalin and lactate dehydrogenase in peritoneal fluids for the screening of bacterial peritonitis 103
Graves Disease In Interferon - Treated and Untreated Patients with Chronic Hepatitis C Virus Infection 102
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 102
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. 102
T and B Cells in Hepatitis C Virus Control: What They Do and When They Fail 101
Reorganization of a large academic hospital to face COVID-19 outbreak: The model of Parma, Emilia-Romagna region, Italy 101
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 101
Cellular immune response to hepatitis B virus antigens. An overview 100
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 100
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 100
Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies? 99
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein 99
Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. 99
The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man 98
Insulin and glucagon levels in fulminant hepatic failure in man 98
Subacute thyroiditis after tick bite 97
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 96
Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine 95
Totale 13.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 0 0 0 0 72 58 35
2021/2022816 23 17 7 48 74 58 47 88 48 26 30 350
2022/20233.180 406 247 168 205 222 361 43 188 1.126 16 142 56
2023/20241.476 82 144 61 76 121 350 92 120 59 89 91 191
2024/20254.869 104 271 290 244 543 595 235 225 660 422 389 891
2025/20269.041 859 1.072 1.102 765 1.303 504 1.067 327 1.386 656 0 0
Totale 22.880